Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study

Jon Erik Fraes Diernæs; Charles Boy Kromann; M Boel; A Bygum; Gregor B E Jemec

doi:10.1016/j.jaad.2021.12.039

Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study

Jon Erik Fraes Diernæs^*, Charles Boy Kromann, M Boel, A Bygum, Gregor B E Jemec

^*Corresponding author af dette arbejde

Dermatologisk Afdeling

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Originalsprog	Engelsk
Sider (fra-til)	920-922
Antal sider	3
Tidsskrift	Journal of the American Academy of Dermatology
Vol/bind	87
Udgave nummer	4
Tidlig onlinedato	30 dec. 2021
DOI	https://doi.org/10.1016/j.jaad.2021.12.039
Status	Udgivet - okt. 2022

Adgang til dokumentet

10.1016/j.jaad.2021.12.039

Citationsformater

@article{6ceb7828090846e59d9c58ef09ea816b,

title = "Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study",

keywords = "Administration, Oral, Antirheumatic Agents/adverse effects, Cohort Studies, Humans, Injections, Subcutaneous, Methotrexate/adverse effects, Patient Reported Outcome Measures, Prospective Studies, Treatment Outcome",

author = "Diern{\ae}s, {Jon Erik Fraes} and Kromann, {Charles Boy} and M Boel and A Bygum and Jemec, {Gregor B E}",

year = "2022",

month = oct,

doi = "10.1016/j.jaad.2021.12.039",

language = "English",

volume = "87",

pages = "920--922",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier",

number = "4",

}

Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate: A prospective, multicenter, paired cohort study. / Diernæs, Jon Erik Fraes; Kromann, Charles Boy; Boel, M et al.
I: Journal of the American Academy of Dermatology, Bind 87, Nr. 4, 10.2022, s. 920-922.

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

TY - JOUR

T1 - Patient-reported adverse effects when switching from oral to subcutaneous administration of methotrexate

T2 - A prospective, multicenter, paired cohort study

AU - Diernæs, Jon Erik Fraes

AU - Kromann, Charles Boy

AU - Boel, M

AU - Bygum, A

AU - Jemec, Gregor B E

PY - 2022/10

Y1 - 2022/10

KW - Administration, Oral

KW - Antirheumatic Agents/adverse effects

KW - Cohort Studies

KW - Humans

KW - Injections, Subcutaneous

KW - Methotrexate/adverse effects

KW - Patient Reported Outcome Measures

KW - Prospective Studies

KW - Treatment Outcome

U2 - 10.1016/j.jaad.2021.12.039

DO - 10.1016/j.jaad.2021.12.039

M3 - Letter

C2 - 34973976

SN - 0190-9622

VL - 87

SP - 920

EP - 922

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 4

ER -